Hepatitis B Vaccine Market By Composition (Combination Vaccines, Mono Vaccines), By End Users Age (Adult Hepatitis B Vaccines, Paediatric Hepatitis B Vaccines) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Factors such as increase in awareness of hepatitis B infection prevention, governments have mandated the immunization and hepatitis B vaccine included in national immunization schedule in many countries driving the market growth of hepatitis B vaccine globally.

The report titled “Hepatitis B Vaccine Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall hepatitis B vaccine market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on composition, end users age and different geographical regions.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global hepatitis B vaccine market, attractive investment proposition and market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the global hepatitis B vaccine market is studied for the following regional markets:   

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global hepatitis B vaccine market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global hepatitis B vaccine market. This report concludes with company profiles section that highlights major information about the key players engaged in global hepatitis B vaccine market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.      

Thus, the research study provides a holistic view of the global hepatitis B vaccine market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Hepatitis B Vaccine Market

For the purpose of this study, the hepatitis B vaccine market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Hepatitis B is life threatening liver disease that can cause acute and chronic liver infection and may lead to cirrhosis and liver cancer. Safe and effective vaccines are available in market to prevent hepatitis B infection. According to World Health Organization (WHO) prevalence of hepatitis B is highest in Western Pacific and in African region more than 6% of the adult population is affected with hepatitis B infection. In South East Asia and European region, it is estimated that 2% and 1.6% of the general population is affected with hepatitis B, respectively. The burden of hepatitis B infection is considerably less in the American population which is approximately 0.7% of the overall population. It is observed that in the base year 2016, North America was major revenue contributing segment. Factors such as higher cost of vaccines, immunization programs and favorable R&D activities driving the market growth in North America. Currently, Asia Pacific is not major revenue generating segment but it is estimated that it will show highest CAGR during forecast period. Rising healthcare awareness, populous countries, increase in awareness of vaccines, government initiative in vaccination program would influence the growth of hepatitis B vaccine market in Asia Pacific region.

Hepatitis B Vaccine Market

Choose License Type
Published Date:  May 2017
Category:  Pharmaceuticals
Report ID:   58438
Report Format:   PDF
Pages:   120
Rating:    4.3 (65)
Connect With Us
+1-408-641-3282
24/7 Research Support